The independent committee investigating Hong Kong’s deadliest fire in decades concluded the first round of hearings last week. It is essential that we get to the bottom of the human and systemic errors that led to the Tai Po inferno. There were many, as anticipated. Fragmentation of responsibility was rampant, which is probably expected for projects of this size with so many parties involved. If t...
The independent committee investigating Hong Kong’s deadliest fire in decades concluded the first round of hearings last week. It is essential that we get to the bottom of the human and systemic errors that led to the Tai Po inferno. There were many, as anticipated. Fragmentation of responsibility was rampant, which is probably expected for projects of this size with so many parties involved. If the government isn’t there to make sure that things are done properly, monitor and enforce the...
Ukrainian President Volodymyr Zelensky has expressed concern that a prolonged US-Israeli war on Iran could further erode America’s support for Ukraine as Washington’s global priorities shift and Kyiv braces for reduced deliveries of critically needed Patriot air-defence missiles. Ukraine desperately needed more US-made Patriot air defence systems to help it counter Russia’s daily barrages, Zelensk...
Ukrainian President Volodymyr Zelensky has expressed concern that a prolonged US-Israeli war on Iran could further erode America’s support for Ukraine as Washington’s global priorities shift and Kyiv braces for reduced deliveries of critically needed Patriot air-defence missiles. Ukraine desperately needed more US-made Patriot air defence systems to help it counter Russia’s daily barrages, Zelensky said, speaking to The Associated Press in an exclusive interview on Saturday in Istanbul. Russia’s...
In late March 2026, Arm Holdings announced its first in-house AI data center chip, the Arm AGI CPU, extending its platform from licensing IP into production silicon for agentic AI workloads in partnership with leading customers such as Meta and major OEMs and cloud providers. Days later, IBM revealed a collaboration with Arm to build dual-architecture hardware for AI and data-intensive enterprise ...
In late March 2026, Arm Holdings announced its first in-house AI data center chip, the Arm AGI CPU, extending its platform from licensing IP into production silicon for agentic AI workloads in partnership with leading customers such as Meta and major OEMs and cloud providers. Days later, IBM revealed a collaboration with Arm to build dual-architecture hardware for AI and data-intensive enterprise workloads, signaling that Arm’s move into CPUs is being woven directly into mission-critical,...
Artem Zakharov/iStock via Getty Images Investment Thesis At first glance, XPEL Inc. ( XPEL ) looks expensive and trades at a premium compared to peers. But in my view, that premium is justified as the fundamentals of the underlying business continue to improve. Based on my analysis, the revenue has the potential to grow, driven by the acquisition of China assets, EBITDA margin recovery, strong FCF...
Artem Zakharov/iStock via Getty Images Investment Thesis At first glance, XPEL Inc. ( XPEL ) looks expensive and trades at a premium compared to peers. But in my view, that premium is justified as the fundamentals of the underlying business continue to improve. Based on my analysis, the revenue has the potential to grow, driven by the acquisition of China assets, EBITDA margin recovery, strong FCF generation, a unique business model with the DAP platform and a company-owned installation center, and a growing addressable market. Furthermore, it is trading at almost half its own 5-year historical EV/EBITDA average. As margins recover to historical levels and increase in revenue from China operations, there is a reasonable case for the valuation multiple to move higher from current levels. The company is a global provider of protective films and coatings for automotive protection. Its products include paint protection films, window film, ceramic coating, and windshield protection film. In terms of channel strategy, it sells products through aftermarket, dealership, OEM, and e-commerce. XPEL Website China Distribution Acquisition: Has Potential to Accelerate Revenue Growth Before the distribution acquisition in China , the operations were managed through a 3rd-party distribution channel partnership. From a business perspective, this was not adding full value to the operations, as XPEL had limited control over pricing decisions, inventory management, or channel development. Through this acquisition, the company can run operations independently now. This is a big stock catalyst, as XPEL now has access to the large automotive market. According to the CAAM analysis of 2025 , China maintained the top global position in automobile production, and sales reached 34.5 million and 34.4 million units, respectively. To understand the significance of this deal, we have to evaluate the latest quarterly results, which are the first full quarter post-acquisition of China distribution a...
Caroline Dubois opens up about her family rift and says she wants to reconcile with her brother Daniel, as she looks to unify lightweight world titles.
Caroline Dubois opens up about her family rift and says she wants to reconcile with her brother Daniel, as she looks to unify lightweight world titles.
Storman/iStock via Getty Images AngioDynamics ( ANGO ) has been looking more and more like a “two steps forward, one and a half steps back” company. Management has inarguably made progress in building the company’s growth-oriented Medical Tech business and boosted the company’s overall growth profile, but quarter-to-quarter performance has remained erratic and unpredictable, and progress in margin...
Storman/iStock via Getty Images AngioDynamics ( ANGO ) has been looking more and more like a “two steps forward, one and a half steps back” company. Management has inarguably made progress in building the company’s growth-oriented Medical Tech business and boosted the company’s overall growth profile, but quarter-to-quarter performance has remained erratic and unpredictable, and progress in margin expansion has likewise been unsteady. AngioDynamics shares are down about 20% since my last update , with two sizable selloffs after the last two quarterly earnings reports tied to growth, margins/reinvestment, and perhaps the pending retirement of the CEO. At this point I do think AngioDynamics shares are likely undervalued, but this is not a stock for investors who get anxious about short-term market reactions. The Med Tech business does appear to be on solid footing, with sizable addressable markets ahead, but there’s still a lot of work to do before these shares will reliably sustain a better multiple. Another Quarter of “Mixed” Trends AngioDynamics’ third quarter offered food for both the bulls and bears, with the latter ultimately winning out on weaker guidance for fourth quarter EBITDA. Revenue rose 9%, beating by about 2%, with the Med Tech business growing 19% (following 13% growth in FQ2, 26% growth in FQ1, and 22% growth in FQ4’25) and the Medical Devices business growing about 1%. AlphaVac continues to perform well off of a small base, logging 47% growth on increased usage in pulmonary embolisms. AngioVac saw 5% growth but a small sequential decline. Auryon rose 18%, which is strong against an underlying market growing in the low double-digits, but I’d frankly been hoping that this business would be consistently growing at 20%+ by now. NanoKnife revenue rose 21%, with probe revenue up 20% (and about 4% sequentially), as usage grows in the wake of FDA approval for prostate cancer and a new CPT code that simplifies reimbursement. Gross margin took a meaningful st...